Press Releases
OAKVILLE, ON, May 1, 2019 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced the details of its Q1 2019 financial results conference call on Friday, May 10, 2019. The call will be hosted by Robert Tessarolo, President and Chief Executive Officer, and Nadine Jutlah, Interim Chief Financial Officer. The Company will issue its financial results on the morning of May 10, 2019.
CONFERENCE CALL DETAILS
DATE: | Friday, May 10, 2019 |
TIME: | 8:30 a.m. EDT |
DIAL IN NUMBER: | (416) 764-8609 or (888) 390-0605 |
CONFERENCE ID: | 57384393 |
REPLAY: | (888) 390-0541 (playback code 384393 #) |
Available until midnight (EDT) May 17, 2019 | |
WEBCAST: | The audio webcast can be accessed at https://cipher.investorroom.com under Investor Relations or at https://event.on24.com/wcc/r/1993654/201373E95BBD2B7681680DAEA05EDB66 |
About Cipher Pharmaceuticals Inc.
Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. Cipher is focused on a three-pronged growth strategy – including acquisitions, in-licensing, and selective investments in drug development – to assemble a broad portfolio of prescription products that serve unmet medical needs. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
